Abstract
Background: We determined circulating anti-S severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) antibody titers in a vaccinated healthcare workers (HCWs) cohort from Northern Israel in the 11 months following primary vaccination according to age, ethnicity, and previous infection status.
Methods: All consenting HCWs were invited to have their IgG levels measured before vaccination and at 6 subsequent timepoints using a quantitative S1/S2 IgG assay. All HCWs with suspected coronavirus disease 2019 (COVID-19) were polymerase chain reaction (PCR) tested. We described trends in circulating IgG geometric mean concentration (GMC) by age, ethnicity, timing of boosting, and previous infection status and compared strata using Kruskall-Wallis tests.
Results: Among 985 vaccinated HCWs, IgG titers between 1 month post 2nd dose to pre-boosting gradually decreased in all age groups. Younger or previously infected individuals had higher initial post-vaccination IgG levels (P < .001 in both cases); differences substantially decreased or disappeared at 7-9 months, before boosting. The proportion of individuals infected prior to initiating vaccination and re-infected after dose 1 was comparable to the proportion of breakthrough infection post-dose 2 in those not previously infected (4.2 vs 4.7%). Pre-infection IgG levels in the 40 participants with breakthrough infection after dose 2 were similar to levels measured at the same timepoint in vaccinated HCWs who remained uninfected (P > .3). Post-dose3 IgG levels were more than 10-fold those 1 month post-dose 2.
Conclusions: Immunity waned in all age groups and previously infected individuals, reversed by boosting. IgG titers decrease and reinfections in individuals with hybrid immunity (infection + vaccination) suggests they may also require further doses. Our study also highlights the difficulty in determining protective IgG levels.
Keywords: COVID-19; Israel; SARS-CoV-2; vaccine immunogenicity; vaccines.
【저자키워드】 COVID-19, SARS-CoV-2, Vaccines., Israel, vaccine immunogenicity, 【초록키워드】 coronavirus disease, IgG, Vaccine, coronavirus, vaccination, Immunity, Vaccines, Infection, healthcare worker, Reinfection, Cohort, PCR, Immunoglobulin, HCWs, Antibody titer, age, Breakthrough infection, Quantitative, Protective, IgG titer, dose, HCW, acute respiratory syndrome, infected individual, infected individuals, individual, all age groups, S1/S2, IgG levels, participant, geometric mean concentration, circulating, doses, anti-S, uninfected, GMC, decrease, highlight, polymerase chain, initial, tested, described, proportion, subsequent, remained, comparable, reversed, all age group, IgG level, re-infected, timepoint, waned, 【제목키워드】 immunogenicity, coronavirus 2, respiratory, hybrid, worker, insight, Against, Month,